You are here: Industry Insights > Insulin

News List

FDA approves first interchangeable biosimilar insulin product europeanpharmaceuticalreview
July 30, 2021
The first interchangeable biosimilar insulin product will help increase access and affordability of insulin for diabetics.
FDA Approves First Biosimilar Insulin Product drugs
July 30, 2021
The first interchangeable biosimilar insulin product has been approved by the U.S. Food and Drug Administration, providing patients with a cost-effective option for treating diabetes, the agency announced Wednesday.
FDA grants interchangeable status to Viatris' biosimilar insulin Semglee firstwordpharma
July 29, 2021
The FDA announced Wednesday that Viatris' biosimilar insulin product Semglee (insulin glargine-yfgn) may now be substituted for its reference product, Sanofi's long-acting insulin analogue Lantus (insulin glargine), without the intervention of a prescribe
FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes fda.gov
July 29, 2021
Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.
Diabetes treatment pump trial begins in Canada europeanpharmaceuticalreview
July 06, 2021
A Phase I trial evaluating Adocia’s BioChaperone® Lispro Pramlintide formulation for insulin pump delivery in type 1 diabetics has begun.
New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association's 81st Scientific Sessions prnasia
July 02, 2021
Gan & Lee Pharmaceuticals Co., Ltd., announced positive Phase 1 clinical trial results at the 81st Scientific Sessions of the American Diabetes Association (ADA), June 25th – 29th.
Walmart to Offer Low-Priced Insulin drugs
June 30, 2021
Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products.
For Losing Weight, Calorie Counting Tops Fasting Diets drugs
June 17, 2021
Intermittent fasting diets are all the rage, but new clinical trial results indicate they don't work any better than simple calorie cutting.
Vaccine slows loss of insulin production in type 1 diabetes genetic subgroup europeanpharmaceuticalreview
June 03, 2021
In a Phase II trial, injecting GAD-alum into the lymph nodes of newly diagnosed type 1 diabetes patients with a genetic variant slowed insulin production degradation.
The American Diabetes Association Praises Introduction of Affordable Insulin for the COVID-19 Emergency Act and the Minority Diabetes Initiative Act prnewswire
March 25, 2021
The American Diabetes Association® (ADA) announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act (H.R. 2179) and the Minority Diabetes Initiative Act (H.R. 2178), both introduced this week by Representative Maxine ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page